Question: is this a 2) strong advice, 1) weak advice 0) no advice?

Our study suggested that treatment of intermediate-risk prostate cancer with definitive dose-escalated EBRT alone resulted in acceptable outcomes, and it failed to show improved outcomes in patients who received short term ADT.
user
This is no advice
assistant